These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3530903)

  • 1. Vitamin K-dependent procoagulant in cancer cells: a potential target for the antimetastatic effect of warfarin?
    Donati MB; Roncaglioni MC; Falanga A; Casali B; Semeraro N
    Haemostasis; 1986; 16(3-4):288-94. PubMed ID: 3530903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer cell procoagulants and their pharmacological modulation.
    Donati MB; Semeraro N
    Haemostasis; 1984; 14(5):422-9. PubMed ID: 6398243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. gamma-Glutamyl carboxylase activity in experimental tumor tissues: a biochemical basis for vitamin K dependence of cancer procoagulant.
    Roncaglioni MC; Dalessandro AP; Casali B; Vermeer C; Donati MB
    Haemostasis; 1986; 16(3-4):295-9. PubMed ID: 3530904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a warfarin-sensitive serum factor that participates in factor X activation by Lewis lung tumor cells.
    Fasco MJ; Wilson AC; Lincoln D; Gierthy J
    Int J Cancer; 1987 May; 39(5):631-7. PubMed ID: 3570555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Warfarin inhibits both procoagulant activity and metastatic capacity of Lewis lung carcinoma cells. Role of vitamin K deficiency.
    Colucci M; Delaini F; de Bellis Vitti G; Locati D; Poggi A; Semeraro N; Donati MB
    Biochem Pharmacol; 1983 Jun; 32(11):1689-91. PubMed ID: 6870908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of the anticoagulant effect of warfarin as evaluated in rabbits by selective depression of individual procoagulant vitamin K-dependent clotting factors.
    Zivelin A; Rao LV; Rapaport SI
    J Clin Invest; 1993 Nov; 92(5):2131-40. PubMed ID: 8227329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct analysis reveals an absence of gamma-carboxyglutamic acid in cancer procoagulant from human tissues.
    Kaplinska K; Mielicki WP
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):315-20. PubMed ID: 19448531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer cell procoagulant: a novel vitamin K-dependent activity.
    Delaini F; Colucci M; De Bellis Vitti G; Locati D; Poggi A; Semeraro N; Donati MB
    Thromb Res; 1981 Nov; 24(3):263-6. PubMed ID: 7336382
    [No Abstract]   [Full Text] [Related]  

  • 9. Warfarin-induced changes in procoagulant and anticoagulant proteins.
    Stirling Y
    Blood Coagul Fibrinolysis; 1995 Jul; 6(5):361-73. PubMed ID: 8589201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of a warfarin-sensitive cancer procoagulant in V2 carcinoma.
    Roncaglioni MC; Falanga A; D'Alessandro AP; Alessio MG; Casali B; Donati MB
    Haematologica; 1989; 74(2):143-7. PubMed ID: 2501168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VKORC1: a warfarin-sensitive enzyme in vitamin K metabolism and biosynthesis of vitamin K-dependent blood coagulation factors.
    Wallin R; Wajih N; Hutson SM
    Vitam Horm; 2008; 78():227-46. PubMed ID: 18374197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of the in vivo anticoagulant, antithrombotic, and antimetastatic efficacy of warfarin in the rat.
    Smith GF; Neubauer BL; Sundboom JL; Best KL; Goode RL; Tanzer LR; Merriman RL; Frank JD; Herrmann RG
    Thromb Res; 1988 Apr; 50(1):163-74. PubMed ID: 3400078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure to warfarin to affect the tissue factor activity and the metastatic potential of murine fibrosarcoma cells.
    Lorenzet R; Bottazzi B; Locati D; Colucci M; Mantovani A; Semeraro N; Donati MB
    Eur J Cancer Clin Oncol; 1985 Feb; 21(2):263-5. PubMed ID: 3987761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A factor X-activating cysteine protease from malignant tissue.
    Gordon SG; Cross BA
    J Clin Invest; 1981 Jun; 67(6):1665-71. PubMed ID: 7016920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives in the treatment of cancer metastasis.
    Garattini S
    Clin Exp Metastasis; 1987; 5(2):105-24. PubMed ID: 3297448
    [No Abstract]   [Full Text] [Related]  

  • 16. Poor correlation of supratherapeutic international normalised ratio and vitamin K-dependent procoagulant factor levels during warfarin therapy.
    Sarode R; Rawal A; Lee R; Shen YM; Frenkel EP
    Br J Haematol; 2006 Mar; 132(5):604-7. PubMed ID: 16445834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Warfarin-induced accumulation of vitamin K-dependent proteins. Comparison between hepatic and non-hepatic tissues.
    Roncaglioni MC; Soute BA; de Boer-vd Berg MA; Vermeer C
    Biochem Biophys Res Commun; 1983 Aug; 114(3):991-7. PubMed ID: 6684427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer procoagulant in human tumor cells: evidence from melanoma patients.
    Donati MB; Gambacorti-Passerini C; Casali B; Falanga A; Vannotti P; Fossati G; Semeraro N; Gordon SG
    Cancer Res; 1986 Dec; 46(12 Pt 1):6471-4. PubMed ID: 3536081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A proteolytic procoagulant associated with malignant transformation.
    Gordon SG
    J Histochem Cytochem; 1981 Mar; 29(3A Suppl):457-63. PubMed ID: 7016982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Several murine metastasizing tumors possess a cysteine proteinase with cancer procoagulant characteristics.
    Falanga A; Bolognese Dalessandro AP; Casali B; Roncaglioni MC; Donati MB
    Int J Cancer; 1987 Jun; 39(6):774-7. PubMed ID: 3294610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.